Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer

PURPOSE: The objective of this multicenter phase II study was to evaluate the efficacy and safety of irinotecan and cisplatin combination chemotherapy in metastatic, unresectable esophageal cancer. MATERIALS AND METHODS: Patients were treated with irinotecan 65 mg/m(2) and cisplatin 30 mg/m(2) on da...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Miso, Keam, Bhumsuk, Kim, Tae-Min, Kim, Hoon-Gu, Kim, Jin-Soo, Lee, Sung Sook, Shin, Seong Hoon, Kim, Min Kyoung, Park, Keon Uk, Kim, Dong-Wan, Yun, Hwan Jung, Lee, Jong Seok, Heo, Dae Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398400/
https://www.ncbi.nlm.nih.gov/pubmed/27488873
http://dx.doi.org/10.4143/crt.2016.121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398400/
https://www.ncbi.nlm.nih.gov/pubmed/27488873
http://dx.doi.org/10.4143/crt.2016.121

Ejemplares similares